Profound Medical Corp
Research Profound Medical Corp (PROF) on Bullrun: market cap USD 264.86M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPROF
- ExchangeNASDAQ
- CountryCanada
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 264.86M
- Financial periodQ2 2026
- RevenueUSD 2.48M
- Net income-USD 9.54M
- Free cash flow-USD 11.34M
- Gross margin78.4%
Valuation Snapshot
latest market cap is USD 264.86M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 16.10M | -USD 42.57M | -USD 38.38M | 70.8% | 1.41 | USD 59.72M | USD 4.50M | USD 66.43M |
| FY2024 | USD 9.74M | -USD 27.82M | -USD 23.45M | 72.2% | 1.12 | USD 54.91M | USD 4.66M | USD 60.42M |
| FY2023 | USD 5.90M | -USD 28.32M | -USD 22.61M | 73.1% | 1.34 | USD 26.21M | USD 7.10M | USD 31.22M |
| FY2022 | USD 6.68M | -USD 28.67M | -USD 25.80M | 45.2% | -1.38 | USD 46.52M | USD 8.23M | USD 52.00M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 264.86M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 285.63M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 225.60M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 181.39M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 227.34M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 233.32M | n/a | n/a | n/a |
About Profound Medical Corp
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Profound Medical Corp's market cap?
Profound Medical Corp's market capitalization is USD 264.86M.
What does Profound Medical Corp do?
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue.